VICTORIA LYNN LANSKI

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care RENO, NV NPI 1851964381

General Payments — all program years on this page

$4,497.94

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $567.02 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $556.1619
Education $10.861

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $600.7215
2023 $3,330.2037
2024 $567.0220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089562726 Insmed, Inc. $21.71 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104210495 AstraZeneca Pharmaceuticals LP $23.03 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104469498 AstraZeneca Pharmaceuticals LP $10.86 11/06/2024 Education Undisputed 01/23/2026 View at CMS
1104488924 AstraZeneca Pharmaceuticals LP $25.31 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104530588 AstraZeneca Pharmaceuticals LP $23.24 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105226753 AstraZeneca Pharmaceuticals LP $21.55 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105468883 AstraZeneca Pharmaceuticals LP $29.67 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114330103 Regeneron Healthcare Solutions, Inc. $30.72 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114330105 Regeneron Healthcare Solutions, Inc. $26.28 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115867041 GlaxoSmithKline, LLC. $21.81 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995717 GlaxoSmithKline, LLC. $28.62 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116079615 GlaxoSmithKline, LLC. $27.69 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116145691 GlaxoSmithKline, LLC. $21.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116368037 GlaxoSmithKline, LLC. $20.54 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116464988 GlaxoSmithKline, LLC. $124.99 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116476554 GlaxoSmithKline, LLC. $22.53 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116619559 GlaxoSmithKline, LLC. $23.41 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146864484 Philips North America LLC $16.91 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146864486 Philips North America LLC $15.71 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146935913 ZOLL Respicardia, Inc. $30.85 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.